Clinical Trial Update: Symptoms of Immune Checkpoint Inhibitor Therapy in Cutaneous Melanoma

View source ↗

Summary

An UCSF-led clinical trial is recruiting to characterize symptoms experienced by patients with cutaneous melanoma treated with immune checkpoint inhibitors, inc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Melanoma

Snippet

Sponsor: University of California, San Francisco | Conditions: Cutaneous Melanoma, Cutaneous Melanoma, Stage III | Status: RECRUITING